Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007;Évolution épidémiologique de souches de Clostridium difficile isolées d'infections dans le CHU Jean-Verdier-René-Muret entre 2001 et 2007

Pathologie Biologie

Volumn 56, Issue 7-8, 2008, Pages 412-416

  Poilane, I ^a   Fantinato, C ^a   Cruaud, P ^a   Collignon, A ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Antibiotic susceptibility; Binary toxin; Clostridium difficile; PCR ribotyping

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; ERYTHROMYCIN; METRONIDAZOLE; MOXIFLOXACIN; QUINOLONE DERIVATIVE; TIGECYCLINE; VANCOMYCIN; ACTIN SPECIFIC ADP RIBOSYLTRANSFERASE, CLOSTRIDIUM; ACTIN-SPECIFIC ADP-RIBOSYLTRANSFERASE, CLOSTRIDIUM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; CORRELATION ANALYSIS; CROSS INFECTION; ENZYME IMMUNOASSAY; EPSILOMETER TEST; FRANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RIBOTYPING; TOXIN ANALYSIS; CLASSIFICATION; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMEMBRANOUS COLITIS; STATISTICS; UNIVERSITY HOSPITAL;

ADP RIBOSE TRANSFERASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; RIBOTYPING; VANCOMYCIN;

EID: 56949101780     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.07.009     Document Type: Article

References (17)

1. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
2. Barbut F., Mastrantonio P., Delmée M., Brazier J., Kuijper E., Poxton I., and European Study Group on Clostridium difficile (ESGCD). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13 (2007) 1048-1057
3. Kuijper E.J., Coignard B., Brazier J., Suetens C., Drudy D., Wiuff C., et al. Update of Clostridium difficile-associated disease due to PCR-ribotype 027 in Europe. Euro Surveill 12 (2007) 163-166
4. Coignard B, Barbut F, Blanckaert K, Thiolet J, Pujol I, Carbonne A et al. Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France 2006. Eurosurveillance 2006;11 (37). Available from:http://www.eurosurveillance.org/ew/2006/060914.asp#1.
5. Bidet P., Barbut F., Lalande V., Burghoffer B., and Petit J.C. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 175 (1999) 261-266
6. Stubbs S., Rupnik M., Gibert M., Brazier J., Duerden B., and Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186 (2000) 307-312
7. Poilane I., Bert F., Cruaud P., Nicolas-Chanoine M.H., and Collignon A. Évaluation de l'antibiogramme par diffusion en milieu gélosé pour le dépistage de souches de Clostridium difficile de sensibilité diminuée aux antibiotiques. Pathol Biol 55 (2007) 429-433
8. Baines S.D., Saxton K., Freeman J., and Wilcox M.H. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model. J Antimicrob Chemother 58 (2006) 1062-1065
9. Hecht D.W., Galang M.A., Sambol S.P., Osmolski J.R., Johnson S., and Gerding D.N. In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 51 (2007) 2716-2719
10. Rupnik M., Grabnar M., and Geric. Binary toxin producing Clostridium difficile strains. Anaerobe 9 (2003) 289-294
11. Goncalves C., Decre D., Barbut F., Burghoffer B., and Petit J.C. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 42 (2004) 1933-1939
12. Geric B., Johnson S., Gerding D.N., Grabnar M., and Rupnik M. Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 41 (2003) 5227-5232
13. Barbut F., Gariazzo B., Bonné L., Lalande V., Burghoffer B., Luiuz R., et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 28 (2007) 131-139
14. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 46 (2008) 431-437
15. Muto C.A. Asymptomatic Clostridium difficile colonization: is this the tip of another iceberg. Clin Infect Dis 45 (2007) 999-1000
16. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L.P., and Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and non epidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45 (2007) 992-998
17. Pépin J., Saheb N., Coulombe M.A., Alary M.E., Corriveau M.P., Authier S., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (2005) 1254-1260